Sign Out
Voriconazole is a broad spectrum, triazole antifungal agent and is indicated as follows: Treatment of invasive aspergillosis.
Treatment of candidemia in non-neutropenic patients.
Treatment of serious invasive Candida infections (including C. krusei).
Treatment of esophageal candidiasis.
Treatment of serious fungal infections caused by Scedosporium spp. and Fusarium spp.
Treatment of other serious fungal infections in patients intolerant of, or refractory to, other therapy.
Prevention of break through of fungal infections in febrile high-risk patients (allogeneic bone marrow transplants, relapsed leukemia patients).
Prophylaxis in patients who are at high risk of developing invasive fungal infections, such as haematopoietic stem cell transplant (HSCT) recipients.
